Rasmus Westermann
Rasmus Westermann is a Medical Doctor and PhD fellow at the Center of Rheumatic Research at Aalborg University in Denmark (CERRA). Currently, Rasmus Westermann is conducting a register-based PhD on the effects of biological/targeted synthetic DMARDs on cancer risk in patients with rheumatoid arthritis. Rasmus Westermann have worked with register-based research using various Danish nationwide administrative registers for five years and within the following rheumatic research areas:
1) The effects of biological/targeted synthetic DMARDs on cancer risk in patients with inflammatory arthritis
2) Cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus
3) COVID-19 and hospitalisation risk in patients with inflammatory arthritis and systemic lupus erythematosus